Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04045652 · ClinicalTrials.gov registry record
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 223
- Enrollment target
NCT04045652 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 223 participants.
The verdict
NCT04045652 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 223 participants
- Enrollment target
Study Summary
This study will utilize a longitudinal study design to better understand the natural history of oncogenic Human Papillomavirus (HPV) infections in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected Kenyan women, including the potentially modifiable (and non-modifiable) factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2015-09-21 |
| Est. Completion | 2020-11-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04045652
The ClinicalTrials.gov registry entry for NCT04045652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04045652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04045652 about?
NCT04045652 is a clinical study titled "Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women". This study will utilize a longitudinal study design to better understand the natural history of oncogenic Human Papillomavirus (HPV) infections in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected Kenyan women, including the potentially modifiable (and non-modifiable) factors that are a...
What is the current status of trial NCT04045652?
This trial is currently completed. The enrollment target is 223 participants. The study started on 2015-09-21. Estimated completion is 2020-11-05.
Who is sponsoring clinical trial NCT04045652?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.